Parents' COVID-19 vaccine intentions for children under 5 years: Brief reflections from a qualitative study
- PMID: 36637082
- DOI: 10.1111/jpc.16312
Parents' COVID-19 vaccine intentions for children under 5 years: Brief reflections from a qualitative study
Abstract
Aim: Australian authorities made COVID-19 vaccines available for children aged under 5 years old with serious comorbidities in August 2022. There is presently no universal programme for young children, but crucial to any rollout's success is whether parents are motivated and able to vaccinate. By examining parents' vaccine intentions, this study aims to inform current and future COVID-19 vaccine roll-outs for children aged under 5 years.
Methods: As part of the mixed methods project 'Coronavax: Preparing Community and Government' we interviewed 18 Western Australian parents of young children about their intentions in late 2021.
Results: Two thirds intended to vaccinate if and when they could, with one third intending to delay for reasons including risk and safety perceptions, fears about side effects and influence from their social networks. However, even those choosing to delay were waiting rather than refusing.
Conclusions: To improve uptake, targeted messaging should emphasise that COVID-19 can be a serious disease in young children, with such messaging drawing on the reputability and esteem of scientific and technical authorities. Such messaging should be oriented towards parents of children with serious comorbidities at the present time. It will be important to emphasise that government vaccine recommendations are based on supporting families to protect their children and keep them healthy.
Keywords: COVID-19; child health; vaccination.
© 2023 The Authors. Journal of Paediatrics and Child Health published by John Wiley & Sons Australia, Ltd on behalf of Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Comment in
-
Letters to the Editor.J Paediatr Child Health. 2023 Mar;59(3):599-600. doi: 10.1111/jpc.16365. Epub 2023 Feb 7. J Paediatr Child Health. 2023. PMID: 36748977 No abstract available.
References
-
- Australian Government: Department of Health and Aged Care. ATAGI Recommendations on COVID-19 Vaccine Use in Children Aged 6 Months to <5 Years [Internet]; 3 August 2022 [cited 2022 Oct 25]. Available from: https://www.health.gov.au/news/atagi-recommendations-on-covid-19-vaccine...
-
- Australian Government Department of Health and Aged Care. ATAGI Recommendations on Use of the Pfizer COVID-19 Vaccine for Children Aged 6 Months to 4 Years. Canberra, Australia: Australian Government; 2022. Available from: https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-pfize...
-
- Tanne JH. Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5 s. BMJ 2022; 377: o1507.
-
- Health Canada. Health Canada Authorizes Use of Moderna COVID-19 Vaccine in Children 6 Months to 5 Years of Age [Internet]; 14 July 2022 [cited 2022 Oct 25]. Available from: https://www.canada.ca/en/health-canada/news/2022/07/health-canada-author...
-
- Leask J, Chow MYK, King C, Booy R. Caregivers' intentions regarding pandemic (H1N1) 2009 influenza vaccination for their children. Med. J. Aust. 2010; 193: 485-6.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials